The Oncology Molecular Diagnostics Market report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. Growing prevalence of cancer across the world is driving the growth of the market. Cancer is the second leading cause of death worldwide, contributed to an estimated 9.6 million deaths in 2018. Approximately 70% of deaths from cancer occur in low- and middle-income countries. Lung, breast, colorectal, prostate, skin cancers are among the most common cancers. The emergence of practical applications of molecular oncology is largely attributed to the development of user-friendly methods of molecular analysis. Growing collaborations has helped overcome barriers imposed by costs and regulatory requirements. However, incomplete disease knowledge, lack of awareness, little intellectual property protection, an uncertain regulatory environment, and no guarantee of reimbursement is hampering the growth of the market.
The major players in the oncology molecular diagnostics market include Cepheid, Beckton Dickinson, Gen Probe (Hologic), Qiagen, Roche Diagnostics, Others.
By Type
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Liver Cancer
- Lung Cancer
- Blood Cancer
- Kidney Cancer
- Other
By Product
- Instruments
- Reagents
By Technology
- PCR
- Multiplex PCR
- In Situ Hybridization
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Chips & Microarrays
- Mass Spectrometry
- Sequencing
- Transcription Mediated Amplification
the oncology molecular diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Source: https://www.valuemarketresearch.com/report/oncology-molecular-diagnostics-market
Naira Shekhawat has been into Content Writing just after completing her Graduation in English Literature. Her love for words has won her many accolades in her respective jobs ever since. Naira covers business sections for VMR News. She is a traveller by heart and loves writing on food blogs as a freelancer.